December 28, 2015 / 1:27 PM / 2 years ago

Valeant to be led by group of senior execs as CEO on medical leave

Dec 28 (Reuters) - Valeant Pharmaceuticals International Inc said a group of company executives will take over in an interim capacity, until CEO Michael Pearson returns from medical leave.

Pearson will be on a medical leave of absence, effective immediately, the company said in a statement on Monday.

Pearson was hospitalized with a "severe case of pneumonia" on Friday and is receiving treatment, a company spokeswoman said on Friday.

Valeant's board has created an "office of the Chief Executive Officer", which will include general counsel Robert Chai-Onn, company group chairman Ari Kellen, and chief financial officer Robert Rosiello. (Reporting by Natalie Grover in Bengaluru; Editing by Shounak Dasgupta)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below